Abstract
Background Evidence is scarce regarding polypharmacy and potentially inappropriate medications (PIMs) in rehabilitation medicine. Aim To investigate the prevalence of polypharmacy and PIMs and their association with outcomes in stroke rehabilitation. Method A retrospective cohort study was conducted with 849 older inpatients post-stroke. Polypharmacy was defined as six or more medications, and PIMs were defined based on Beers criteria 2019. Study outcomes included functional independence measure (FIM)-motor, FIM-cognitive, energy intake, dysphagia, length of hospital stay, and the rate of home discharge. To consider the effect of pharmacotherapy during rehabilitation, multivariate analyses were used to determine whether the presence of polypharmacy or PIMs at discharge was associated with outcomes. Results After enrollment, 361 patients (mean age 78.3 ± 7.7 years; 49.3% male) were analyzed. Polypharmacy was observed in 43.8% and 62.9% of patients, and any PIMs were observed in 64.8% and 65.4% of patients at admission and discharge, respectively. The most frequently prescribed PIMs included antipsychotics, benzodiazepines, and proton pump inhibitors. Polypharmacy was negatively associated with FIM-motor score (β = − 0.062, P = 0.049), FIM-cognitive score (β = − 0.076, P = 0.014), energy intake (β = − 0.143, P = 0.005), and home discharge (OR: 0.458; 95% CI: 0.248, 0.847; P = 0.013). PIMs were negatively associated with home discharge (OR: 0.375; 95% CI: 0.195, 0.718; P = 0.003). Conclusion Polypharmacy and PIMs are commonly found among older patients undergoing stroke rehabilitation. Moreover, polypharmacy was negatively associated with activities of daily living (ADL) but not with PIMs and ADLs, and both were associated with home discharge.
Similar content being viewed by others
References
Novaes PH, da Cruz DT, Lucchetti ALG, et al. The “iatrogenic triad”: polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults. Int J Clin Pharm. 2017;39:818–25.
Calderón-Larrañaga A, Poblador-Plou B, González-Rubio F, et al. Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well? Br J Gen Pract. 2012;62:e821–6.
Green JL, Hawley JN, Rask KJ. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother. 2007;5:31–9.
Suzuki T, Iwagami M, Hamada S, et al. Number of consulting medical institutions and risk of polypharmacy in community-dwelling older people under a healthcare system with free access: a cross-sectional study in Japan. BMC Health Serv Res. 2020;20:1–9.
Kalisch LM, Caughey GE, Roughead EE, Gilbert AL, et al. The prescribing cascade. Austral Prescriber. 2011;34:162–6.
Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol. 2003;38:843–53.
Doan J, Zakrzewski-Jakubiak H, Roy J, et al. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Ann Pharmacother. 2013;47:324–32.
Pasina L, Brucato AL, Falcone C, et al. Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging. 2014;31:283–9.
Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13:57–65.
Kojima T, Akishita M, Nakamura T, et al. Polypharmacy as a risk for fall occurrence in geriatric outpatients. Geriatr Gerontol Int. 2012;12:425–30.
Martin NJ, Stones MJ, Young JE, et al. Development of delirium: a prospective cohort study in a community hospital. Int Psychogeriatr. 2000;12:117–27.
Fried TR, O’Leary J, Towle V, et al. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62:2261–72.
Fick DM, Semla TP, Steinman M, et al. American geriatrics society 2019 updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67:674–94.
Glass J, Lanctôt KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331:1169.
Manias E, Kabir MZ, Maier AB. Inappropriate medications and physical function: a systematic review. Ther Adv Drug Saf. 2021;12:20420986211030372.
Fick DM, Mion LC, Beers MH, et al. Health outcomes associated with potentially inappropriate medication use in older adults. Res Nurs Health. 2008;31:42–51.
Jensen LD, Andersen O, Hallin M, et al. Potentially inappropriate medication related to weakness in older acute medical patients. Int J Clin Pharm. 2014;36:570–80.
Wakabayashi H. Rehabilitation pharmacotherapy: a combination of rehabilitation and pharmacotherapy. J Gen Fam Med. 2018;19:43–4.
Kose E, Toyoshima M, Okazoe S, et al. The relationship between polypharmacy and recovery of activities of daily living among convalescent stroke patients: a propensity score-matched analysis. Eur Geriatr Med. 2017;8:250–5.
Kose E, Hirai T, Seki T. Clinical factors affecting potentially inappropriate medications at discharge in older stroke patients. Eur Geriatr Med. 2018;9:161–8.
Kose E, Wakabayashi H. Rehabilitation pharmacotherapy a scoping review. Geriatrics and Gerontology International. Hoboken: Blackwell Publishing; 2020. p. 655–63.
Shigematsu K, Nakano H, Watanabe Y. The eye response test alone is sufficient to predict stroke outcome–reintroduction of Japan Coma Scale: a cohort study. BMJ Open. 2013;3: e002736.
Rubenstein LZ, Harker JO, Salvà A, et al. Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci. 2001;56:M366–72.
Kunieda K, Ohno T, Fujishima I, et al. Reliability and validity of a tool to measure the severity of dysphagia: the Food Intake LEVEL Scale. J Pain Symptom Manag. 2013;46:201–6.
Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.
Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007;38:1091–6.
Ottenbacher KJ, Hsu Y, Granger CV, et al. The reliability of the functional independence measure: a quantitative review. Arch Phys Med Rehabil. 1996;77(12):1226–32.
Kaido T, Uemoto S. Direct segmental multi-frequency bioelectrical impedance analysis is useful to evaluate sarcopenia. Am J Transplant. 2013;13:2506–7.
Chen L-K, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21:300-307.e2.
Salinas-Rodríguez A, Manrique-Espinoza B, Rivera-Almaraz A, et al. Polypharmacy is associated with multiple health-related outcomes in Mexican community-dwelling older adults. Salud Publica Mex. 2020;62:246–54.
Yuki A, Otsuka R, Tange C, et al. Polypharmacy is associated with frailty in Japanese community-dwelling older adults. Geriatr Gerontol Int. 2018;18:1497–500.
Bushardt RL, Massey EB, Simpson TW, et al. Polypharmacy: misleading, but manageable. Clin Interv Aging. 2008;3:383–9.
Kojima T, Akishita M, Kameyama Y, et al. High risk of adverse drug reactions in elderly patients taking six or more drugs: analysis of inpatient database. Geriatr Gerontol Int. 2012;12:761–2.
Masnoon N, Shakib S, Kalisch-Ellett L, et al. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:1–10.
Sawaya AL, Tucker K, Tsay R, et al. Evaluation of four methods for determining energy intake in young and older women: comparison with doubly labeled water measurements of total energy expenditure. Am J Clin Nutr. 1996;63:491–9.
Kus S, Müller M, Strobl R, et al. Patient goals in post-acute geriatric rehabilitation–goal attainment is an indicator for improved functioning. J Rehabil Med. 2011;43:156–61.
Kido Y, Yoshimura Y, Wakabayashi H, et al. Sarcopenia is associated with incontinence and recovery of independence in urination and defecation in post-acute rehabilitation patients. Nutrition. 2021;91–92: 111397.
Beninato M, Gill-Body KM, Salles S, et al. Determination of the minimal clinically important difference in the FIM instrument in patients with stroke. Arch Phys Med Rehabil. 2006;87:32–9.
Nishioka S, Aragane H, Suzuki N, et al. Clinical practice guidelines for rehabilitation nutrition in cerebrovascular disease, hip fracture, cancer, and acute illness: 2020 update. Clin Nutr ESPEN. 2021;43:90–103.
Oyanagi K, Kitai T, Yoshimura Y, et al. Effect of early intensive rehabilitation on the clinical outcomes of patients with acute stroke. Geriatr Gerontol Int. 2021;21:623–8.
Yoshimura Y, Wakabayashi H, Momosaki R, et al. Shorter interval between onset and admission to convalescent rehabilitation wards is associated with improved outcomes in ischemic stroke patients. Tohoku J Exp Med. 2020;252:15–22.
Yoshimura Y, Bise T, Nagano F, et al. Systemic inflammation in the recovery stage of stroke: its association with sarcopenia and poor functional rehabilitation outcomes. Prog Rehabil Med. 2018;3:20180011.
Shimazu S, Yoshimura Y, Kudo M, et al. Frequent and personalized nutritional support leads to improved nutritional status, activities of daily living, and dysphagia after stroke. Nutrition. 2021;83:111091.
Ye Z, Reintam Blaser A, Lytvyn L, et al. Gastrointestinal bleeding prophylaxis for critically ill patients: a clinical practice guideline. BMJ. 2020;368:l6722.
Kamada T, Satoh K, Itoh T, et al. Evidence-based clinical practice guidelines for peptic ulcer disease 2020. J Gastroenterol. 2021;56:303–22.
Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50:E344-418.
Kose E, Hirai T, Seki T, et al. The association of increased drugs use with activities of daily living and discharge outcome among elderly stroke patients. Int J Clin Pharm. 2018;40:599–607.
Heuberger RA, Caudell K. Polypharmacy and nutritional status in older adults. Drugs Aging. 2011;28:315–23.
Wolf U, Eckert S, Walter G, et al. Prevalence of oropharyngeal dysphagia in geriatric patients and real-life associations with diseases and drugs. Sci Rep. 2021;11:1–14.
Kose E, Hirai T, Seki T, et al. Role of potentially inappropriate medication use in rehabilitation outcomes for geriatric patients after strokes. Geriatr Gerontol Int. 2018;18:321–8.
Vluggen TPMM, van Haastregt JCM, Tan FES, et al. Factors associated with successful home discharge after inpatient rehabilitation in frail older stroke patients. BMC geriatr. 2020;20:25.
Chang F-H, Ni P, Jette AM. Does activity limitation predict discharge destination for postacute care patients? Am J Phys Med Rehabil. 2014;93:782–90.
Everink IHJ, van Haastregt JCM, van Hoof SJM, et al. Factors influencing home discharge after inpatient rehabilitation of older patients: a systematic review. BMC Geriatr. 2016;16:5.
Yoshimura Y, Wakabayashi H, Bise T, et al. Sarcopenia is associated with worse recovery of physical function and dysphagia and a lower rate of home discharge in Japanese hospitalized adults undergoing convalescent rehabilitation. Nutrition. 2019;61:111–8.
Kose E, Hirai T, Seki T. Psychotropic drug use and cognitive rehabilitation practice for elderly patients. Int J Clin Pharm. 2018;40:1292–9.
Gamble J-M, Hall JJ, Marrie TJ, et al. Medication transitions and polypharmacy in older adults following acute care. Ther Clin Risk Manag. 2014;10:189–96.
Mixon AS, Neal E, Bell S, et al. Care transitions: a leverage point for safe and effective medication use in older adults–a mini-review. Gerontology. 2015;61:32–40.
Clarke CL, Witham MD. The effects of medication on activity and rehabilitation of older people—opportunities and risks. Rehabil Process Outcome. 2017;6:1179572717711433.
Willoch K, Blix HS, Pedersen-Bjergaard AM, et al. Handling drug-related problems in rehabilitation patients: a randomized study. Int J Clin Pharm. 2012;34:382–8.
O’mahony D, O’sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–8.
Acknowledgements
We would like to express our deepest gratitude to the Nutrition Support Team of Kumamoto Rehabilitation Hospital for their support of this study.
Funding
This research did not receive any funding from agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors have no conflicts of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Matsumoto, A., Yoshimura, Y., Nagano, F. et al. Polypharmacy and potentially inappropriate medications in stroke rehabilitation: prevalence and association with outcomes. Int J Clin Pharm 44, 749–761 (2022). https://doi.org/10.1007/s11096-022-01416-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-022-01416-5